References: Hospital-acquired pneumonia

  • Abbas M, Robalo Nunes T, Martischang R, Zingg W, Iten A, Pittet D, et al. Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers. Antimicrob Resist Infect Control 2021;10(1):7. https://www.ncbi.nlm.nih.gov/pubmed/33407833
  • Abdul-Aziz MH, Hammond NE, Brett SJ, Cotta MO, De Waele JJ, Devaux A, et al. Prolonged vs Intermittent Infusions of beta-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis. JAMA 2024;332(8):638-48. https://pubmed.ncbi.nlm.nih.gov/38864162/
  • Ackerman A, Zook NR, Siegrist JF, Brummitt CF, Cook MM, Dilworth TJ. Comparison of Clinical Outcomes among Intensive Care Unit Patients Receiving One or Two Grams of Ceftriaxone Daily. Antimicrob Agents Chemother 2020;64(6). https://www.ncbi.nlm.nih.gov/pubmed/32205348
  • American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171(4):388-416. https://www.ncbi.nlm.nih.gov/pubmed/15699079
  • Borman AM, Johnson EM. Name Changes for Fungi of Medical Importance, 2018 to 2019. J Clin Microbiol 2021;59(2). https://www.ncbi.nlm.nih.gov/pubmed/33028600
  • Chang Y, Jeon K, Lee SM, Cho YJ, Kim YS, Chong YP, et al. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study. J Korean Med Sci 2021;36(41):e251. https://www.ncbi.nlm.nih.gov/pubmed/34697926
  • Costa RD, Baptista JP, Freitas R, Martins PJ. Hospital-Acquired Pneumonia in a Multipurpose Intensive Care Unit: One-Year Prospective Study. Acta Med Port 2019;32(12):746-53. https://www.ncbi.nlm.nih.gov/pubmed/31851883
  • Dulhunty JM, Brett SJ, De Waele JJ, Rajbhandari D, Billot L, Cotta MO, et al. Continuous vs Intermittent beta-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial. JAMA 2024;332(8):629-37. https://pubmed.ncbi.nlm.nih.gov/38864155/
  • Ehrenzeller S, Klompas M. Association Between Daily Toothbrushing and Hospital-Acquired Pneumonia: A Systematic Review and Meta-Analysis. JAMA Intern Med 2023. https://www.ncbi.nlm.nih.gov/pubmed/38109100
  • Garin N, Marti C, Skali Lami A, Prendki V. Atypical Pathogens in Adult Community-Acquired Pneumonia and Implications for Empiric Antibiotic Treatment: A Narrative Review. Microorganisms 2022;10(12). https://www.ncbi.nlm.nih.gov/pubmed/36557579
  • Gijsen M, Dreesen E, Van Daele R, Annaert P, Debaveye Y, Wauters J, et al. Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study. Antibiotics (Basel) 2021;10(5). https://www.ncbi.nlm.nih.gov/pubmed/34064676
  • Hagel S, Schmitt S, Kesselmeier M, Baier M, Welte T, Ewig S, et al. M. pneumoniae and C. pneumoniae are no relevant pathogens in critically ill patients with hospital-acquired respiratory tract infections. Infection 2019;47(3):471-4. https://www.ncbi.nlm.nih.gov/pubmed/30689160
  • Hartman SJF, Upadhyay PJ, Hagedoorn NN, Mathot RAA, Moll HA, van der Flier M, et al. Current Ceftriaxone Dose Recommendations are Adequate for Most Critically Ill Children: Results of a Population Pharmacokinetic Modeling and Simulation Study. Clin Pharmacokinet 2021;60(10):1361-72. https://www.ncbi.nlm.nih.gov/pubmed/34036552
  • Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016;63(5):e61-e111. https://www.ncbi.nlm.nih.gov/pubmed/27418577
  • Mouth Care Matters. Mouth Care Matters: Toolkit for Improving Mouth Care in Hospitals. London: Health Education England; 2019. version 12. Accessed 21 September 2023. https://mouthcarematters.hee.nhs.uk/links-resources/mouth-care-matters-resources-2/index.html
  • National Institute for Clinical Excellence (NICE). Pneumonia (hospital-acquired): antimicrobial prescribing. London: Public Health England; 2019. Updated September 2019. Accessed 21 Sept 2023. https://www.nice.org.uk/guidance/NG139
  • Passaro L, Harbarth S, Landelle C. Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review. Antimicrob Resist Infect Control 2016;5:43. https://www.ncbi.nlm.nih.gov/pubmed/27895901
  • Smith S, Hanson J, Currie BJ. Melioidosis: An Australian Perspective. Trop Med Infect Dis 2018;3(1). https://www.ncbi.nlm.nih.gov/pubmed/30274424
  • Suaya JA, Fletcher MA, Georgalis L, Arguedas AG, McLaughlin JM, Ferreira G, et al. Identification of Streptococcus pneumoniae in hospital-acquired pneumonia in adults. J Hosp Infect 2021;108:146-57. https://www.ncbi.nlm.nih.gov/pubmed/33176175
  • Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J 2017;50(3). https://www.ncbi.nlm.nih.gov/pubmed/28890434
  • US Food and Drug Administration (FDA). Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Developing Drugs for Treatment: Guidance for Industry. Silver Spring, MD: FDA; 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia-developing-drugs
  • Weiss E, Essaied W, Adrie C, Zahar JR, Timsit JF. Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials. Crit Care 2017;21(1):162. https://www.ncbi.nlm.nih.gov/pubmed/28655326